Acute diarrhoea is most often viral or bacterial gastroenteritis lasting < 5 days, self-limiting with oral rehydration. The MedsBase Diarrhoea Treatment catalogue stocks the standard symptomatic and aetiological agents.
Stocked options. Loperamide (peripheral mu-opioid receptor agonist that slows bowel transit — useful for symptomatic relief in non-invasive diarrhoea) is stocked as Imodium. Nitazoxanide (broad-spectrum antiprotozoal / anthelmintic — first-line for cryptosporidium and giardia, useful in selected viral and chronic diarrhoeal contexts) as Nizonide. Rifaximin (luminal-acting antibiotic for IBS-D, traveller’s diarrhoea, hepatic encephalopathy) as Rifagut. Browse our Αντιβιοτικά catalogue for azithromycin and ciprofloxacin (used as standby antibiotics for traveller’s diarrhoea).
How to use. Mild watery diarrhoea, no fever or blood — oral rehydration solutions (ORS) + symptomatic loperamide if needed (avoid in invasive bloody diarrhoea or fever). Suspected giardiasis or cryptosporidiosis (chronic / recurrent / immunocompromised) → nitazoxanide. Suspected SIBO or persistent post-infectious IBS-D → rifaximin 2-week course. Travel-related diarrhoea — see our Traveller’s Diarrhoea Treatment category for stand-by antibiotic regimens.
Σημαντικό. Severe diarrhoea (more than 6 watery stools/day for 2+ days), bloody diarrhoea, fever, signs of dehydration, severe abdominal pain, or recent antibiotic exposure (Clostridioides difficile risk) warrants urgent medical assessment rather than self-treatment with loperamide. Loperamide is contraindicated in invasive infection (Salmonella, Shigella, EHEC) — it can prolong infection and precipitate megacolon or HUS. Children with diarrhoea — focus on rehydration; avoid loperamide in children < 6 years. All MedsBase products ship from WHO-GMP πιστοποιημένους κατασκευαστές and are covered by our Πολιτική Εγγύησης Επαναποστολής.